Peter A. Barry, Ph.D.

Infectious Diseases Unit
Core Scientist

Dept. of Pathology and Laboratory Medicine
UC Davis School of Medicine


Dr. Barry has characterized the natural history of RhCMV infection in colony macaques, and his laboratory develops key reagents and techniques to investigate molecular, virological, and immunological parameters of animals infected with this virus.  He is evaluating the pathogenic potential of modified RhCMV-based SIV vaccine vectors.  In addition, he is conducting a comprehensive analysis of maturation of the macaque immune system.

Email Dr. Barry

Visit Dr. Barry’s UC Davis webpage

Highlight summary of Dr. Barry’s research (PDF)

Human CMV Vaccine

'Novel vaccine approach to human cytomegalovirus found effective' An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, was safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus. (From: